[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.194.83. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correction
November 14, 2012

Error in Text in: Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial

JAMA. 2012;308(18):1861. doi:10.1001/jama.2012.14674

Error in Text. In the Original Contribution entitled “Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial” published in the July 11, 2012, of JAMA (2012;308[2]:147-156), the median survival for the ampullary pancreatobiliary group was transposed with the median survival for the ampullary intestinal group. This article has been corrected online.

×